Councils - Pulmonary Transplantation
Scientific Council on Pulmonary Transplantation
COUNCIL LEADERSHIP OPERATING BOARD NOT A COUNCIL MEMBER
Council membership is open to all ISHLT members. Joining is easy. Simply login to the ISHLT Members Only Website
where you can update your membership profile and join any of the 12 Scientific Councils.
Location: Acropolis Congrès Centre, Nice, France
ISHLT 38th Annual Meeting and Scientific Sessions
The resources below were developed by the ISHLT Pulmonary Transplantation Council QOL Workforce for clinicians and investigators alike. These resources aim to provide organized, up-to-date summaries of information focused on HRQL in lung transplantation.
This annotated bibliography of peer-reviewed publications focused on HRQL in lung transplantation is organized by theme including:
I. Determinants of HRQL
II. Psychosocial factors in HRQL
III. Comparisons of HRQL before and after lung transplantation
IV. Long-term longitudinal studies of HRQL in lung transplant recipients
V. The effect of therapies and interventions on HRQL
VI. Instrument validation and methodology
VII. HRQL as a predictor of clinical outcomes
VIII. Reviews and Editorials
This table is an organized list of the HRQL, health status and utility instruments used in studies examining HRQL in lung transplantation. In addition, links to the original manuscript that introduced each instrument and to the instrument webpage (if available) are provided.
If you are aware of new articles or resources that are missing, please email email@example.com
Orlando, FL, USADr. Cynthia Gries is the Medical Director of the Lung Transplant Program at Florida Hospital in Orlando, Florida. Dr. Gries attended medical school at the University of Chicago. She completed her internal medicine residency at Johns Hopkins University in Baltimore, MD and completed her fellowship at the University of Washington in Seattle, WA where she completed her masters in Epidemiology. Dr. Gries' main research focus is improving the long-term outcomes in lung transplant patients.
Washington University School of Medicine
Barnes Jewish Hospital
St. Louis, MO, USADr. Hachem is currently the Tracey C. Marshall – Dr. Elbert P. Trulock Distinguished Professor of Medicine at Washington Univ in St. Louis. He is the Medical Director of the Lung Transplant Program at Washington University and Barnes-Jewish Hospital. His research interests include the role of humoral immunity in allograft rejection and the management of chronic lung allograft dysfunction.
Melbourne, AUSTRALIABio coming soon...
University of Washington School of Medicine
Seattle, Washington, USADr. Michael S. Mulligan is an Endowed Professor in Lung Transplant Research, Chief of the Thoracic Surgery Section, Director of the Lung Transplant Program and Minimally Invasive Surgery Program as well as Director of the Cardiothoracic Research Laboratory at the Univ of Washington, Seattle, Washington, and one of the only surgeons in the Pacific Northwest who performs pulmonary endarterectomies for chronic pulmonary embolic disease. His laboratory has been consistently funded by the NIH and investigates mechanisms involved in acute lung transplant dysfunction.
The Prince Charles Hospital
Brisbane, AUSTRALIADr Peter Hopkins is the Director of the Queensland Lung Transplant Service and Associate Professor with the School of Medicine, Univ of Queensland, Brisbane. Research interests include First in Man clinical trials of innovative bronchoscopic techniques of lung volume reduction and development of novel treatment strategies for interstitial lung disease. Executive positions are held with the Australian Lung Foundation (PIVOT and the Australian IPF Registry), Deputy Chair of the Lung Standing Committee Transplant Society of Australia and New Zealand, Convenor SIG Interventional Bronchoscopy Thoracic Society of Australia and New Zealand and National Examiners Panel Royal Australian College of Physicians.
University of California, San Francisco
San Francisco, CA, USALorriana Leard, MD is an Associate Professor of Clinical Medicine at UCSF where she is the Chief of Clinical Operations for the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine and the Associate Program Director for the Pulmonary and Critical Care Fellowship Program. Her primary interests are in medical education and lung transplantation.
University of Pennsylvania
Philadephia, PA, USADenis Hadjiliadis, MD, joined the Univ of Pennsylvania in 2005 and has been the Adult Program Director of the Cystic Fibrosis Program since 2009, while remaining active at the Penn Lung Transplant Program. He is currently the Paul F. Harron Jr. Associate Prof of Medicine at the Perelman SoM of the Univ of Pennsylvania.
University of Washington
Seattle, WA, USAErika Lease, MD, is the Medical Director of the Lung Transplant Program at the University of Washington in Seattle, Washington, and an Associate Professor within the Division of Pulmonary, Critical Care, and Sleep Medicine. She also attends on the Solid Organ Transplant Infectious Disease service.
UC San Francisco
San Francisco, CA, USADr. Jonathan Singer is a transplant pulmonologist and Assistant Professor of Medicine in the Division of Pulmonary, Critical Care, Allergy and Sleep Medicine at the University of California, San Francisco. At UCSF, he is the Associate Medical Director of Lung Transplant Outcomes Research and is a core investigator with the UCSF Respiratory Epidemiology Group. His research focuses broadly on how lung transplantation improves patient-centered outcomes including functioning, disability, health-related quality of life, and survival. An area of particular interest is how frailty and refined assessments of body composition impact patient-centered outcomes in lung transplant candidates and recipients.
LIAISONS TO OTHER COUNCILS:
University Health Network
Toronto, ON, CANADAJussi Tikkanen is originally from Helsinki, Finland but currently works as a lung transplant physician in the Toronto Lung Transplant Program. His research interests include donor-specific antibodies, primary graft dysfunction, and chronic lung allograft dysfunction.
University of Pittsburgh
Pittsburgh, PA, USAPablo G Sanchez, MD PhD, is a Lung Transplant Surgeon. He is the Associate Director of Lung Transplant and the Adult ECLS program and the Director of Ex vivo Lung Perfusion and Lung Transplant Research at the University of Pittsburgh. He is a national co-investigator for the NOVEL trial, evaluating the use of ex vivo perfusion to increase lung donor use. He received the F. Griffith Pearson Fellowship from The American Association for Thoracic Surgery. He has also received funding from the Maryland Stem Cell Research Foundation, the ISHLT research fellowship award and the University of Maryland and Living Legacy Foundation Transplantation Grant Program Award.
Stanford, CA, USADr. Joshua Mooney is a Clinical Assistant Professor at Stanford University who specializes in the care of interstitial lung disease and lung transplant patients. He performs health services and outcomes research focused on improving the lives and care of patients with advanced lung disease and is actively involved in clinical trials to improve outcomes in interstitial lung disease.
Tampa General Hospital
Tampa, FL, USANicole Davis has been a lung transplant coordinator at Tampa General Hospital for the past 3 years. Prior to that she worked as a transplant nurse clinician for 5 years. She received her BSN and MPH from East Carolina University. Her focus is currently on process improvement within the pre and post lung transplant clinics at Tampa General Hospital.